Article

University of Tennessee to feature lecture by glaucoma expert, M. Bruce Shields, MD

Glaucoma expert M. Bruce Shields, MD, will lecture at the Hamilton Eye Institute at the University of Tennessee (UT) Health Science Center Department of Ophthalmology.

Memphis, TN-Glaucoma expert M. Bruce Shields, MD, will deliver a lecture associated with the 15th Annual William N. Williford, MD, Distinguished Visiting Professorship at the Hamilton Eye Institute at the University of Tennessee (UT) Health Science Center Department of Ophthalmology in Memphis on Sept. 13.

After 15 years as chairman of the Yale School of Medicine, Dr. Shields holds the title of Marvin L. Sears Professor Emeritus of Ophthalmology and Visual Science and chairman emeritus. Before working at Yale, he was a faculty member in the department of ophthalmology at Duke University for 22 years, during which time he directed the glaucoma service, developing laser treatments to treat advanced glaucoma.

In 2006, Dr. Shields patented a glaucoma treatment device (Aquashunt, Opko Health) that reduces IOP by allowing excess fluid in the eye to exit naturally. He has written more than 200 scientific journal articles and book chapters. His best-known work, Textbook of Glaucoma, is now in its sixth U.S. edition and has been translated into German, Japanese, Portuguese, and Spanish.

The annual lecture at the Hamilton Eye Institute is named for an anterior segment and cataract surgeon and an alumnus of the UT Department of Ophthalmology. Dr. Williford is a fellow of the American Academy of Ophthalmology and the American College of Surgeons; and he is a member of the American Medical Association, the Tennessee Academy of Ophthalmology, and the Knoxville Academy of Medicine. He established the distinguished visiting professorship in 1997.

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Eric D. Donnenfeld, MD, on the effect of lifitegrast clinical signs and biomarkers in dry eye disease
(Image credit: Ophthalmology Times) The Residency Report: Clinical insights from the iStent infinite trial
(Image credit: Ophthalmology Times) ASCRS 2025: Amar Shah, MD, on why hyperosmolar tear film before and after cataract surgery matters
© 2025 MJH Life Sciences

All rights reserved.